| J9271 | Injection, pembrolizumab, 1 mg | 9,600 | $40 | $412.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 41,250 | $1 | $41.3K |
| J0897 | Injection, denosumab, 1 mg | 2,220 | $20 | $40K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 590 | $50 | $30.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 220 | $80 | $18.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $90 | $15.7K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 7,060 | $1 | $14.1K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 50 | $120 | $6.4K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 110 | $60 | $6.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 120 | $40 | $5.1K |